Spero Therapeutics (SPRO)'s 30-day implied volatility (IV30) was 65.5% at the close on November 3, 2026, up from 54.0% the day before, against a 52-week range of 35.5% to 154.7%. Its 20-day historical volatility was 68.5%.
Data as of November 3, 2026.